US Patent 9132192 Anti-EGFR antibodies and uses thereof
Patent 9132192 was granted and assigned to Regeneron Pharmaceuticals on September, 2015 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
June 25, 2013
0
Date of Patent
September 15, 2015
0
Patent Applicant
Patent Application Number
13925923
0
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9132192 Anti-EGFR antibodies and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
